Photo from MSKCC/X
Jul 4, 2024, 10:46
Dr. Eytan Stein to lead a novel clinical trial for AML patients
Memorial Sloan Kettering Cancer Center shared on X:
“A new class of drugs known as menin inhibitors could stop the most lethal form of acute myeloid leukemia.
Research a decade ago paved the way for MSK hematologic oncologist Dr. Eytan Stein to lead a groundbreaking clinical trial for AML patients. Read more.”
Source: Memorial Sloan Kettering Cancer Center/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 21, 2025, 08:19
Feb 21, 2025, 06:20
Feb 20, 2025, 11:19
Feb 20, 2025, 11:13
Feb 20, 2025, 11:08
Feb 20, 2025, 11:00